EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms

Tsewang Tashi, Michael W Deininger

Immunology and Allergy Clinics of North America · 2023

DOI: 10.1016/j.iac.2023.04.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2023. Verfasst von Tsewang Tashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, 2000, Circle of Hope, Salt Lake City, UT 84112, U…. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Hematologic Neoplasms, Myeloproliferative Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced systemic mastocytosis (AdvSM) is a heterogeneous group of disorders characterized by neoplastic mast cell-related organ damage and frequently associated with a myeloid neoplasm. The 3 clinical entities that comprise AdvSM are aggressive SM (ASM), SM-associated hematologic neoplasm, and mast cell leukemia. A gain-of-function KIT D816 V mutation is the primary oncogenic driver found in about 90% of all patients with AdvSM. Midostaurin, an oral multikinase inhibitor with activity against KIT D816V, and avapritinib, an oral selective KIT D816V inhibitor are approved for AdvSM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mastocytosis, SystemicHematologic NeoplasmsMyeloproliferative DisordersHumansProto-Oncogene Proteins c-kitDisease ManagementProtein Kinase InhibitorsStaurosporineMutation

Stichwörter der Autor:innen

Associated hematologic neoplasmAvapritinibKIT D816 VKIT inhibitorsSystemic mastocytosisTryptase

Substanzen

Proto-Oncogene Proteins c-kitProtein Kinase InhibitorsStaurosporinemidostaurinKIT protein, human

Autor:innen und Institutionen

  • Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, 2000, Circle of Hope, Salt Lake City, UT 84112, USA. Electronic address: tsewang.tashi@utah.edu.
  • Division of Hematology and Oncology, Medical College of Wisconsin, Versiti Blood Research Institute, 8727 West Watertown Plank Road, Milwaukee, WI 53226, USA.

Zitieren

APA

Tashi, T., & Deininger, M. W. (2023). Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2023.04.009

Vancouver

Tashi T, Deininger MW. Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms. Immunology and Allergy Clinics of North America. 2023. doi:10.1016/j.iac.2023.04.009

BibTeX
@article{Tashi2023,
  author = {Tashi, Tsewang and Deininger, Michael W},
  title = {Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2023},
  doi = {10.1016/j.iac.2023.04.009}
}
Kostenlos starten →